Minister for Information Technology, Biotechnology and Rural Development Priyank Kharge said the state will unveil an Ocean Farming Policy, back AI–biotech convergence, and push a greener data ...
News-Medical.Net on MSN
New nanoparticle separation method boosts biotech and cancer research
In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves ...
Experts highlight biotechnology's potential to drive sustainable growth and career opportunities in India's emerging ...
VIR-5500 ASCO GU update, VIR-5818 H2’26, ECLIPSE 1 Q4’26 + more hepatitis delta readouts. See more details here.
Goldman Sachs believes that Biohaven offers investors an under-the-radar opportunity to invest in a potentially best-in-class ...
Biotechnology is the exploitation of biological processes for the development of technologies and products for a specific use. GlobalData’s Strategic Intelligence report on biotech details how recent ...
Over in Grant, the Tennessee Valley Authority awarded funding to a science class at Kate Duncan Smith DAR Middle School to ...
This board strengthens Serpin Pharma’s ability to advance innovative immune‑modulating therapeutics and expand our ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...
Zacks Investment Research on MSN
Is Invesco Biotechnology & Genome ETF (PBE) a strong ETF right now?
The Invesco Biotechnology & Genome ETF (PBE) was launched on 06/23/2005, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market. What ...
Zacks Investment Research on MSN
Should you invest in the Invesco Biotechnology & Genome ETF (PBE)?
The Invesco Biotechnology & Genome ETF (PBE) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Biotech segment of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results